| 摘要 |
A sustained release, solid pharmaceutical preparation for oral use in a daily dosage regimen is provided, which comprises at least one sparingly soluble main drug, such as an erythromycin derivative. The pharmaceutical preparation comprises the main drug(s), a water-soluble alginate salt and an organic carboxylic acid. In particular, a controlled release tablets of clarithromycin is provided.
|
